Abbott Labs' Humira receives positive opinion from European Medicines Agency for the treatment of Crohns disease
Co announces that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, granted a positive opinion recommending approval of Humira for the treatment of severe Crohn's disease.
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters